PT862915E - Composicao antibacteriana para administracao oral - Google Patents

Composicao antibacteriana para administracao oral

Info

Publication number
PT862915E
PT862915E PT96933635T PT96933635T PT862915E PT 862915 E PT862915 E PT 862915E PT 96933635 T PT96933635 T PT 96933635T PT 96933635 T PT96933635 T PT 96933635T PT 862915 E PT862915 E PT 862915E
Authority
PT
Portugal
Prior art keywords
oral administration
antibacterial composition
antibacterial
composition
oral
Prior art date
Application number
PT96933635T
Other languages
English (en)
Inventor
Kenichi Abe
Masato Ota
Hiroyuki Yamaguchi
Chikako Murakami
Toshihiro Kikkoji
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of PT862915E publication Critical patent/PT862915E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
PT96933635T 1995-10-13 1996-10-14 Composicao antibacteriana para administracao oral PT862915E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26584795 1995-10-13

Publications (1)

Publication Number Publication Date
PT862915E true PT862915E (pt) 2002-09-30

Family

ID=17422903

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96933635T PT862915E (pt) 1995-10-13 1996-10-14 Composicao antibacteriana para administracao oral

Country Status (16)

Country Link
US (1) US5958915A (pt)
EP (1) EP0862915B1 (pt)
KR (1) KR100311576B1 (pt)
CN (1) CN1102046C (pt)
AR (1) AR004014A1 (pt)
AT (1) ATE214930T1 (pt)
BR (1) BR9610836A (pt)
CA (1) CA2234426C (pt)
DE (1) DE69620220T2 (pt)
ES (1) ES2174109T3 (pt)
HK (1) HK1016477A1 (pt)
HU (1) HU224922B1 (pt)
MX (1) MX9802849A (pt)
PT (1) PT862915E (pt)
TW (1) TW458778B (pt)
WO (1) WO1997013516A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302082B6 (cs) * 1998-01-07 2010-09-29 Meiji Seika Kaisha Ltd. Prostredek zahrnující krystalograficky stabilní amorfní cefalosporin a zpusob jeho výroby
SK287674B6 (sk) * 1998-11-02 2011-05-06 Elan Pharma International Limited Mnohočasticový prostriedok s modifikovaným uvoľňovaním obsahujúci metylfenidát, pevná orálne dávková forma s jeho obsahom a jeho použitie
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
JP4827367B2 (ja) * 2000-11-21 2011-11-30 杏林製薬株式会社 ドライシロップ剤
EP1364643A4 (en) * 2000-12-01 2009-07-15 Kyowa Hakko Kogyo Kk COMPOSITION WITH IMPROVED ORAL SOLUBILITY OR ABSORBABILITY
US20030060451A1 (en) * 2001-05-29 2003-03-27 Rajneesh Taneja Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
CA2449002C (en) 2001-05-29 2011-08-16 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
TW200306868A (en) * 2002-05-22 2003-12-01 Shionogi & Co Composition of hardly soluble medicine with improved solubility
AUPS303202A0 (en) * 2002-06-20 2002-07-11 Pacific Biolink Pty Limited Protein based oral lubricant
AU2003235962A1 (en) 2002-10-02 2004-04-23 Meiji Seika Kaisha, Ltd. Antibacterial medicinal composition of enhanced oral absorptivity
WO2005034957A1 (ja) * 2003-10-08 2005-04-21 Meiji Seika Kaisha, Ltd. セフジトレン ピボキシルを含有する非晶性抗菌組成物
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
KR20070086324A (ko) 2004-11-16 2007-08-27 쓰리엠 이노베이티브 프로퍼티즈 컴파니 칼슘과 인을 방출하는 유리를 함유한 치과용 조성물
AU2005306868B2 (en) * 2004-11-16 2011-06-09 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
WO2006055329A2 (en) 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers including a phosphorus-containing surface treatment
KR101439724B1 (ko) 2004-11-16 2014-09-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 포스페이트 염을 포함하는 치과용 충전제 및 조성물
JP2009517485A (ja) 2005-06-08 2009-04-30 エラン・ファルマ・インターナショナル・リミテッド セフジトレンを含むナノ粒子状および制御放出組成物
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
US8790707B2 (en) 2008-12-11 2014-07-29 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2012010938A2 (en) * 2010-07-23 2012-01-26 Lupin Limited Pharmaceutical compositions of cefditoren pivoxil
WO2016114727A1 (en) 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
CN105663058A (zh) * 2016-02-01 2016-06-15 济南康和医药科技有限公司 一种头孢妥仑匹酯纳米粒药物制剂及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936609A (ja) * 1982-08-26 1984-02-28 Nitto Electric Ind Co Ltd 粘着性貼付製剤
JPS59184122A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
JPS60102168A (ja) * 1983-11-08 1985-06-06 Tsukishima Shokuhin Kogyo Kk エイコサペンタエン酸強化乳化物及び食品の製造方法
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPH0678234B2 (ja) * 1988-04-19 1994-10-05 明治製菓株式会社 経口投与用抗菌組成物
JPH0635394B2 (ja) * 1989-02-28 1994-05-11 雪印乳業株式会社 薬物の溶解性および吸収性の改善方法
JPH0717866A (ja) * 1993-06-16 1995-01-20 Meiji Seika Kaisha Ltd 医薬組成物
JPH0840907A (ja) * 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤

Also Published As

Publication number Publication date
ES2174109T3 (es) 2002-11-01
EP0862915B1 (en) 2002-03-27
US5958915A (en) 1999-09-28
AR004014A1 (es) 1998-09-30
BR9610836A (pt) 1999-07-13
WO1997013516A1 (fr) 1997-04-17
KR100311576B1 (ko) 2001-12-28
HK1016477A1 (en) 1999-11-05
HUP9900609A3 (en) 2001-04-28
DE69620220D1 (de) 2002-05-02
CA2234426A1 (en) 1997-04-17
MX9802849A (es) 1998-11-30
DE69620220T2 (de) 2002-11-28
TW458778B (en) 2001-10-11
CN1102046C (zh) 2003-02-26
CN1202110A (zh) 1998-12-16
HU224922B1 (en) 2006-04-28
ATE214930T1 (de) 2002-04-15
EP0862915A1 (en) 1998-09-09
CA2234426C (en) 2003-07-08
HUP9900609A2 (hu) 1999-07-28
KR19990064137A (ko) 1999-07-26
EP0862915A4 (en) 1998-11-11

Similar Documents

Publication Publication Date Title
PT862915E (pt) Composicao antibacteriana para administracao oral
PT812195E (pt) Composicao farmaceutica para compostos de piperidinoalcanol
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
NO20004345L (no) Farmasøytisk sammensetning
IS4706A (is) Lyfjasamsetningar
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
BR9508844A (pt) Composição oral
BR9506536A (pt) Composição oral
PT868911E (pt) Formulacoes de rapamicina para administracao oral
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
LV11727A (lv) Farmaceitiska kompozicija
BR9507768A (pt) Composição farmacêutica
FI973229A0 (fi) Uusi farmaseuttinen koostumus
ID18698A (id) Komposisi farmasi
BR9607433A (pt) Composição farmacêutica para administração parental
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
FI962738A0 (fi) Farmaseuttiset koostumukset
NO964309D0 (no) Farmasöytisk sammensetning
ITMI950120A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402925D0 (sv) Novel oral pharmaceutical composition
SE9402924D0 (sv) Novel pharmaceutical composition
KR960016881A (ko) 제약 조성물
SE9402437D0 (sv) Pharmaceutical composition